Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 1,109.85
-19.35 (-1.71%)
At close: Jan 23, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 11.52 billion as of January 23, 2026. Its market cap has increased by 22.99% in one year.
Market Cap
11.52B
Enterprise Value
12.26B
Revenue
4.23B
Ranking
n/a
PE Ratio
23.46
Stock Price
1,109.85
Market Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 11.52B, an increase of 4,888.09%. That is a compound annual growth rate of 50.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 11.52B | 0.14% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 17.43B |
| Bliss GVS Pharma | 16.61B |
| TTK Healthcare | 14.16B |
| Syncom Formulations (India) | 11.05B |
| Fermenta Biotech | 9.74B |
| Venus Remedies | 9.64B |
| Lincoln Pharmaceuticals | 9.07B |
| Bharat Parenterals | 7.63B |